• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Gilead Surges on Remdesivir Report: How to Play the Stock Now

We have a new price target for GILD.
By BRUCE KAMICH
Apr 17, 2020 | 09:12 AM EDT
Stocks quotes in this article: GILD

Shares of Gilead Sciences Inc. (GILD)  are soaring Friday morning on a report of preliminary results from a study in Chicago evaluating the company's remdesivir drug in severely ill Covid-19 patients. Many of these patients saw rapid recoveries in fever and respiratory symptoms and almost all patients were discharged in less than a week. Pretty impressive and very encouraging.

We last covered GILD on April 7 where we wrote, "Part of the art of technical analysis is using the right kind of chart and indicators at that particular point in time. Sometimes a candlestick chart is better than a bar chart at turning points and sometimes momentum is a better tool at tops and bottoms than the MACD oscillator. Experience. GILD is in an uptrend and traders and investors could use available weakness to go long. Risk a close below $69."  

In the updated daily bar chart of GILD, below, we can see that prices have kept up their frantic up-and-down trading pattern. Prices have still made higher lows over the past week and have stayed above the rising 50-day moving average line. The 200-day moving average line still has a positive slope but I would not have expected otherwise.

The On-Balance-Volume (OBV) line and the Moving Average Convergence Divergence (MACD) oscillator have continued their short-term jiggles. 

 
In the weekly bar chart of GILD, below, we can see that prices have made a rounded bottom pattern or some may call it a saucer pattern or even a cup-and-handle pattern. The results are more important than what we label the action. 
 
 
In this monthly bar chart of GILD, below, we get the 35,000-foot view. Here we can imagine that prices could head back to the highs of 2014-15.
 
 
In this weekly Point and Figure chart of GILD, below, we can see a potential upside price target of $95. 
 
 
Bottom-line strategy: Longs could raise sell stop protection to a close below $72 for now. Our new price target is $95.
 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Biotechnology | Healthcare | Pharmaceuticals | Coronavirus

More from Stocks

Is the Uptick in Inflation Just a Blip?

Bret Jensen
Apr 14, 2021 9:00 AM EDT

If investors start to factor in higher inflation, we could be looking at a big increase in volatility in the months ahead.

What's the Logical Approach on Logitech?

Bruce Kamich
Apr 14, 2021 8:42 AM EDT

Let's check out LOGI's charts and indicators and find out.

Has DraftKings Corrected Enough to Warrant Purchase?

Bruce Kamich
Apr 14, 2021 8:03 AM EDT

Let's wait and see if we get a test of the top end of the $53-$48 area.

Bank Earnings and Coinbase in the Spotlight as Traders Struggle

James "Rev Shark" DePorre
Apr 14, 2021 7:43 AM EDT

There has been a lack of energy in the market, but things did perk up late Tuesday.

Bank Earnings, Late Day Market Surges, Vaccine Update, Trading Coinbase

Stephen Guilfoyle
Apr 14, 2021 7:33 AM EDT

Perhaps the most interesting result of an inflationary but not frightening CPI was visible in U.S. Treasury security markets.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:42 PM EDT PAUL PRICE

    Wednesday on Real Money Pro

    Make this stock a 'part' of your portfolio.
  • 04:44 PM EDT PAUL PRICE

    Pretty Incredible + Hard to Believe

  • 11:18 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 5 Pillars of Exceptional Trading
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login